CNS immune privilege: hiding in plain sight - PubMed (original) (raw)
Review
CNS immune privilege: hiding in plain sight
Monica J Carson et al. Immunol Rev. 2006 Oct.
Abstract
Central nervous system (CNS) immune privilege is an experimentally defined phenomenon. Tissues that are rapidly rejected by the immune system when grafted in sites, such as the skin, show prolonged survival when grafted into the CNS. Initially, CNS immune privilege was construed as CNS isolation from the immune system by the blood-brain barrier (BBB), the lack of draining lymphatics, and the apparent immunoincompetence of microglia, the resident CNS macrophage. CNS autoimmunity and neurodegeneration were presumed automatic consequences of immune cell encounter with CNS antigens. Recent data have dramatically altered this viewpoint by revealing that the CNS is neither isolated nor passive in its interactions with the immune system. Peripheral immune cells can cross the intact BBB, CNS neurons and glia actively regulate macrophage and lymphocyte responses, and microglia are immunocompetent but differ from other macrophage/dendritic cells in their ability to direct neuroprotective lymphocyte responses. This newer view of CNS immune privilege is opening the door for therapies designed to harness autoreactive lymphocyte responses and also implies (i) that CNS autoimmune diseases (i.e. multiple sclerosis) may result as much from neuronal and/or glial dysfunction as from immune system dysfunctions and (ii) that the severe neuronal and glial dysfunction associated with neurodegenerative disorders (i.e. Alzheimer's disease) likely alters CNS-specific regulation of lymphocyte responses affecting the utility of immune-based therapies (i.e. vaccines).
Figures
Fig. 1
Microglial morphology is an inaccurate predictor of juxtaposition with cerebrovasculature. (A) Three apparently stellate Iba-1+cells in the CNS of a healthy adult mouse are identified in green. (B) All nuclei in the same tissue section are identified in blue with DAPI. (C) All myeloid cells and blood vessels are identified in red with tomato lectin. (D) Merged images of all three panels illustrates close juxtaposition of cell 1 but not that of cells 2 and 3 with blood vessels. Confocal images were taken using a Zeiss. A rotating three-dimensional image is provided online as Supplemental Movie 1.
Fig. 2. The genotype of resident microglia and peripheral immune cells can be differentially manipulated using irradiation bone marrow chimeric methodology.
(A) Rodents receive whole-body irradiation sufficient to kill the adult bone marrow stem cell population. (B) To survive, irradiated rodents must receive bone marrow from a donor. The genotype of the donor and recipient can differ. (C) The donor bone marrow contributes to the repopulation of the peripheral immune system but not to that of most the CNS myeloid population (see text for discussion).
Similar articles
- The movers and shapers in immune privilege of the CNS.
Engelhardt B, Vajkoczy P, Weller RO. Engelhardt B, et al. Nat Immunol. 2017 Feb;18(2):123-131. doi: 10.1038/ni.3666. Epub 2017 Jan 16. Nat Immunol. 2017. PMID: 28092374 Review. - Balancing function vs. self defense: the CNS as an active regulator of immune responses.
Carson MJ, Sutcliffe JG. Carson MJ, et al. J Neurosci Res. 1999 Jan 1;55(1):1-8. doi: 10.1002/(SICI)1097-4547(19990101)55:1<1::AID-JNR1>3.0.CO;2-9. J Neurosci Res. 1999. PMID: 9890428 Review. - Immune privilege and HIV-1 persistence in the CNS.
Persidsky Y, Poluektova L. Persidsky Y, et al. Immunol Rev. 2006 Oct;213:180-94. doi: 10.1111/j.1600-065X.2006.00440.x. Immunol Rev. 2006. PMID: 16972904 Review. - The Diverse Roles of Microglia in the Neurodegenerative Aspects of Central Nervous System (CNS) Autoimmunity.
Thompson KK, Tsirka SE. Thompson KK, et al. Int J Mol Sci. 2017 Feb 25;18(3):504. doi: 10.3390/ijms18030504. Int J Mol Sci. 2017. PMID: 28245617 Free PMC article. Review.
Cited by
- Neurobartonelloses: emerging from obscurity!
Bush JC, Robveille C, Maggi RG, Breitschwerdt EB. Bush JC, et al. Parasit Vectors. 2024 Oct 5;17(1):416. doi: 10.1186/s13071-024-06491-3. Parasit Vectors. 2024. PMID: 39369199 Free PMC article. Review. - Unraveling the causative connection between urticaria, inflammatory cytokines, and mental disorders: Perspectives from genetic evidence.
Liu Z, Wang Y, Wang S, Wu J, Jia C, Tan X, Liu X, Huang X, Zhang L. Liu Z, et al. Skin Res Technol. 2024 Sep;30(9):e13906. doi: 10.1111/srt.13906. Skin Res Technol. 2024. PMID: 39300828 Free PMC article. - Advancements and challenges: immunotherapy therapy in high-grade glioma - a meta-analysis of randomized clinical trials.
Palavani LB, Mitre LP, Camerotte R, Nogueira BV, Canto GL, Chen HC, Pacheco-Barrios N, Ferreira MY, Batista S, Andreão FF, Polverini AD, Montenegro TS, Paiva W, Ferreira C, Bertani R, D'Amico RS. Palavani LB, et al. J Neurooncol. 2024 Sep 4. doi: 10.1007/s11060-024-04813-0. Online ahead of print. J Neurooncol. 2024. PMID: 39230804 Review. - Roles in Innate Immunity.
Church KA, Cardona AE, Hopp SC. Church KA, et al. Adv Neurobiol. 2024;37:263-286. doi: 10.1007/978-3-031-55529-9_15. Adv Neurobiol. 2024. PMID: 39207697 Review. - Evolution of Microglia.
Guffart E, Prinz M. Guffart E, et al. Adv Neurobiol. 2024;37:39-51. doi: 10.1007/978-3-031-55529-9_3. Adv Neurobiol. 2024. PMID: 39207685
References
- Lo D, et al. Integrating innate and adaptive immunity in the whole animal. Immunol Rev. 1999;169:225–239. - PubMed
- Grigoriadis N, Grigoriadis S, Polyzoidou E, Milonas I, Karussis D. Neuroinflammation in multiple sclerosis: evidence for autoimmune dysregulation, not simple autoimmune reaction. Clin Neurol Neurosurg. 2006;108:241–244. - PubMed
- Elward K, Gasque P. “Eat me” and “don't eat me” signals govern the innate immune response and tissue repair in the CNS: emphasis on the critical role of the complement system. Mol Immunol. 2003;40:85–94. - PubMed
- Rosenberg GA. Matrix metalloproteinases in neuroinflammation. Glia. 2002;39:279–291. - PubMed
Publication types
MeSH terms
Grants and funding
- R01 NS039508-01A1S1/NS/NINDS NIH HHS/United States
- R01 NS045735-03/NS/NINDS NIH HHS/United States
- R01 NS039508-05/NS/NINDS NIH HHS/United States
- R01 NS039508-01A1/NS/NINDS NIH HHS/United States
- R01 NS045735-02/NS/NINDS NIH HHS/United States
- R01 NS039508-02/NS/NINDS NIH HHS/United States
- R01 NS045735-05/NS/NINDS NIH HHS/United States
- R01 NS045735-01/NS/NINDS NIH HHS/United States
- R01 NS039508-03/NS/NINDS NIH HHS/United States
- R01 NS045735/NS/NINDS NIH HHS/United States
- R01 NS039508-06/NS/NINDS NIH HHS/United States
- R01 NS039508/NS/NINDS NIH HHS/United States
- R01 NS039508-04/NS/NINDS NIH HHS/United States
- R01 NS045735-04/NS/NINDS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources